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Dear Editor,
The Letter to the Editor from Jentsch
and colleagues presents an alternate,
heretofore unpublished mechanism char-
acterizing the role of ClC-3 in pancreatic
b cells. This alternative mechanism is in
contrast to the mechanism put forth in
our paper (Deriy et al., 2009) and that of
Li and colleagues (Li et al., 2009), which
were published back to back in Cell
Metabolism. The focus of the critique
from Jentsch et al. rests on the absence
of data within our investigation demon-
strating that the antibody used in the
immunoelectron microscopy studies
fails to recognize protein in Clcn3/ ani-
mals. Although specificity of the antibody
has been shown elsewhere, we include
confirming antibody specificity data in
our response. We also include staining
using a commercially available antibody
shown for comparison. Figure S1 com-
pares immunolocalization in Clcn3+/+ and
Clcn3/ preparations with the antibody
(anti-ClC-3730-744) used by Deriy et al.
(2009). We were unable to observe stain-
ing in the Clcn3/ tissue. Other issues
raised by Jentsch et al., referring to
‘‘contradictions’’ between our paper and
that of Li et al., are likely due310 Cell Metabolism 12, October 6, 2010 ª20to slight differences in methodology. Our
study measured glucose-stimulated
insulin secretion (GSIS) from isolated
islets every minute using an automated
continuous-flow perifusion system, and
KCl was added to the islets following
long periods of GSIS. Using a static incu-
bation system, Li et al. measured total
insulin released over a period of 1 hr and
performed glucose and KCl stimulation in
separate experiments. The Letter to the
Editor by Jentsch and colleagues
suggests that the observed differences in
insulin secretion are due to abnormally
high leptin levels in the Clcn3/ animal.
We have not measured leptin in our
animal, nor have we seen the data that
Jentsch et al. claim to have obtained
from b cell-specific ClC-3 knockout
animals, so at this time we cannot deter-
mine what effect, if any, leptin might
have had on our experiments. The islets
and cells used in these experiments were
kept in culture for 16–48 hr prior to exper-
imentation, ruling out acute effects of lep-
tin. Insulin content inWTandKO isletswas
identical, arguing against effects on insulin
transcription. We therefore find it unlikely
that all the functional defects in Clcn3/
b cells—impaired insulin processing,10 Elsevier Inc.exocytosis, and granule acidification—
could be due to alterations in serum leptin.
In summary, the two published papers
came to identical conclusions using two
different Clcn3/ animal strains, two
different antibodies, and multiple func-
tional assays.SUPPLEMENTAL INFORMATION
Supplemental Information includes one figure and
can be found with this article online at doi:10.
1016/j.cmet.2010.09.005.
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